×
Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar Disorder PDF
$ 40.00
Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar Disorder PDF quantity
$ 40.00
×
Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter? PDF
$ 40.00
Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter? PDF quantity
$ 40.00
×
Using Stimulants for Attention-Deficit/Hyperactivity Disorder: Clinical Approaches and Challenges PDF
$ 40.00
Using Stimulants for Attention-Deficit/Hyperactivity Disorder: Clinical Approaches and Challenges PDF quantity
$ 40.00
×
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF
$ 40.00
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF quantity
$ 40.00
×
Diabetes Insipidus Secondary to Combination Atypical Antipsychotic and Lithium Use in a Bipolar Disorder Patient: A Case Report PDF
$ 40.00
Diabetes Insipidus Secondary to Combination Atypical Antipsychotic and Lithium Use in a Bipolar Disorder Patient: A Case Report PDF quantity
$ 40.00
×
Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features PDF
$ 40.00
Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
